Creative Enzymes Announces Upgrade of Industrial Enzyme Production Platform

(Creative Enzymes) Creative Enzymes, a leading Contract Development and Manufacturing Organization (CDMO) focused on enzyme-related projects, today announced the upgrade of its industrial enzyme production platform. The new platform covers the entire workflow from feasibility assessment and strain development to large-scale fermentation, purification, and final filling. Production capacity is flexible and adjustable, supporting both gram-scale research batches and ton-scale industrial manufacturing.

Unlike traditional small-molecule products, industrial enzymes are produced by "living factories"—bacteria, yeast, or mammalian cells. That's where the complexity of the production process begins. The challenges often come down to a few key issues: low expression levels, enzymes that keep losing activity during processing, and poor purification and recovery efficiency. To tackle these challenges, Creative Enzymes integrates microbiology, molecular biology, fermentation, and downstream processing into a unified platform, connecting the upstream and downstream workflows to achieve efficient synergy.

With over ten years of experience in enzyme production, the company has developed exclusive solutions tailored to diverse industrial needs. The industrial enzyme production services include feasibility assessment to evaluate technical and commercial viability, bioinformatics and strain improvement to enhance yield and stability, trial fermentation and sampling to optimize expression performance, industrial enzyme activity assay, purification and recovery strategies tailored to each enzyme, and finish and fill into liquid, solid, or stabilized formats with rigorous quality control.

Creative Enzymes has demonstrated its industrial enzyme capabilities through multiple successful programs. In one case, optimization of fermentation conditions for Thermus thermophilus HB8 led to a 70-fold increase in extracellular thermostable amylase titers, reaching 76 U/mL and remaining fully stable after 24 hours at 80 °C. In another case, supplementation with 5 mM manganese enhanced secretion efficiency of cyclomaltodextrinase by 5.3 times in a food-grade Bacillus subtilis system, a practical strategy for improving industrial enzyme yield and usability. The company also performs industrial enzyme purity & stability analysis to support process validation.

The industrial enzyme production platform supports diverse sectors including food and beverage for starch processing and baking, bioenergy for cellulosic ethanol and biodiesel, pharmaceuticals for API synthesis, and environmental management for bioremediation and wastewater treatment. Creative Enzymes also provides comprehensive technology transfer with detailed documentation and experimental data to support client manufacturing operations.

"Our industrial enzyme production platform eliminates the typical bottlenecks in scale-up, helping clients move from concept to commercialization faster and more cost-effectively," said Dr. Charles, Head of Purification Sciences at Creative Enzymes. "By integrating upstream and downstream processes while maintaining strict quality standards, we deliver reliable, scalable, and cost-effective solutions that meet the demanding requirements of modern industrial applications."

Creative Enzymes' production platform features production efficiency prediction using modeling tools, seamless scale-up from development to manufacturing, flexible capacities from grams to tons, upstream process optimization of culture conditions and media composition, downstream processing development for efficient purification, and quality control systems to ensure product consistency and compliance.

Creative Enzymes is a premier provider of enzyme, probiotic, and biochemical solutions for research and industrial use. With over ten years of experience in industrial enzyme development and manufacturing, the company serves clients worldwide, offering comprehensive solutions from discovery to commercial production. The company's platform enables efficient production from gram-scale research quantities to ton-scale manufacturing, supported by robust process development and seamless technology transfer capabilities.

For research and industrial use only. Not intended for human therapeutic use. Certain food-grade products are suitable for formulation development in food and related applications. READ MORE